Wang Xin, Hadjichristidis Nikos
Physical Sciences and Engineering Division, KAUST Catalysis Center, Polymer Synthesis Laboratory, King Abdullah University of Science and Technology (KAUST), Thuwal 23955, Saudi Arabia.
ACS Macro Lett. 2020 Apr 21;9(4):464-470. doi: 10.1021/acsmacrolett.0c00040. Epub 2020 Mar 18.
We report a series of poly(ester amide)s (PEAs) synthesized by organocatalytic ring-opening polymerization (ROP) of -acylated-1,4-oxazepan-7-one (OxP) monomers, produced from -acylated-4-piperidones using the Baeyer-Villiger oxidation reaction. The ROP of OxPs, conducted in CHCl at room temperature with benzyl alcohol as initiator and TBD/TU (1,5,7-triazabicyclo[4.4.0]dec-5-ene/thiourea) as a binary organocatalytic system, revealed a controlled/living character. The thermodynamics of the ROP highly depends on the -acylated substituent of monomers, with the following reactivity order: OxP > OxP > OxP > OxP. Based on NMR results, it seems that our system follows the hydrogen bonding bifunctional activation mechanism. All intermediates and final products were characterized by NMR, MALDI-TOF MS, SEC, and DSC techniques. All poly(-acylated-1,4-oxazepan-7-one) (POxP) polymers are amorphous with different glass transition temperatures (), depending on the -acylated substituent (: -2.90 to 43.75 °C). Among the synthesized polymers, only POxP was water-soluble and it degraded much faster than polycaprolactone in an aqueous phosphate buffer saline solution (pH = 7.4). Therefore, poly(-acylated-1,4-oxazepan-7-one)s are potential biodegradable alternatives to poly(2-oxazoline)s.
我们报道了一系列通过有机催化开环聚合(ROP)由β-酰化-1,4-恶唑烷-7-酮(OxP)单体合成的聚(酯酰胺)(PEA),这些单体是由β-酰化-4-哌啶酮通过拜耳-维利格氧化反应制备的。在室温下于CHCl₃中以苄醇为引发剂、TBD/TU(1,5,7-三氮杂双环[4.4.0]癸-5-烯/硫脲)为二元有机催化体系进行OxP的ROP反应,显示出可控/活性特征。ROP反应的热力学高度依赖于单体的β-酰化取代基,反应活性顺序如下:OxP > OxP > OxP > OxP。基于核磁共振结果,我们的体系似乎遵循氢键双功能活化机制。所有中间体和最终产物均通过核磁共振、基质辅助激光解吸电离飞行时间质谱、尺寸排阻色谱和差示扫描量热法技术进行了表征。所有聚(β-酰化-1,4-恶唑烷-7-酮)(POxP)聚合物均为无定形,具有不同的玻璃化转变温度(Tg),这取决于β-酰化取代基(Tg范围为-2.90至43.75 °C)。在合成的聚合物中,只有POxP是水溶性的,并且在磷酸盐缓冲盐水溶液(pH = 7.4)中其降解速度比聚己内酯快得多。因此,聚(β-酰化-1,4-恶唑烷-7-酮)是聚(2-恶唑啉)潜在的可生物降解替代品。